Global Cancer Mouse Models Market 2022 by Company, Regions, Type and Application, Forecast to 2028

Page: 124

Published Date: 03 Jun 2022

Category: Service & Software

PDF Download

Get FREE Sample

Customize Request

Description
Table of Contents
Table of Figures
Research Methodology
Companies Mentioned
Related Reports
Product Tags

Description

The Cancer Mouse Models market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

According to our (Global Info Research) latest study, due to COVID-19 pandemic, the global Cancer Mouse Models market size is estimated to be worth US$  million in 2021 and is forecast to a readjusted size of USD  million by 2028 with a CAGR of  % during forecast period 2022-2028. Contract Research Organizations accounting for  % of the Cancer Mouse Models global market in 2021, is projected to value USD  million by 2028, growing at a  % CAGR in next six years. While Humanized Immune System Mouse Models segment is altered to a  % CAGR between 2022 and 2028.

Global key companies of Cancer Mouse Models include The Jackson Laboratory, Taconic Biosciences, Charles River Laboratories, Shanghai Model Organisms Center Inc., and Envigo, etc. In terms of revenue, the global top four players hold a share over  % in 2021.

Market segmentation
Cancer Mouse Models market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type, covers
    Humanized Immune System Mouse Models
    Syngeneic Tumor Mouse Models
    Immunodeficient Mouse Models
    NOG Mouse Models
    Spontaneous Tumor Mouse Models
    Others

Market segment by Application, can be divided into
    Contract Research Organizations
    Pharma and Biopharma Companies
    Academic and Research Institutes

Market segment by players, this report covers
    The Jackson Laboratory
    Taconic Biosciences
    Charles River Laboratories
    Shanghai Model Organisms Center Inc.
    Envigo
    Biocytogen
    Genoway
    Crown Bioscience Inc. (JSR Corporation).
    Cyagen
    Applied stem cells
    Ingenious Targeting Laboratory
    PolyGene - Transgenic mice model company
    Creative Biolabs
    TransCure Bioservices
    Champions Oncology Inc
    Certis Oncology
    Signature
    Pharmaron
    Laboratory Corporation of America Holdings
    Gempharmatech
    Janvier Labs
    Harbour BioMed

Market segment by regions, regional analysis covers
    North America (United States, Canada, and Mexico)
    Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
    Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
    South America (Brazil, Argentina, Rest of South America)
    Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)

The content of the study subjects, includes a total of 12 chapters:
Chapter 1, to describe Cancer Mouse Models product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top players of Cancer Mouse Models, with revenue, gross margin and global market share of Cancer Mouse Models from 2019 to 2022.
Chapter 3, the Cancer Mouse Models competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with revenue and growth rate by Type, application, from 2017 to 2028.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2017 to 2022.and Cancer Mouse Models market forecast, by regions, type and application, with revenue, from 2023 to 2028.
Chapter 11 and 12, to describe Cancer Mouse Models research findings and conclusion, appendix and data source.

Table of Contents

1 Market Overview
    1.1 Product Overview and Scope of Cancer Mouse Models
    1.2 Classification of Cancer Mouse Models by Type
        1.2.1 Overview: Global Cancer Mouse Models Market Size by Type: 2017 Versus 2021 Versus 2028
        1.2.2 Global Cancer Mouse Models Revenue Market Share by Type in 2021
        1.2.3 Humanized Immune System Mouse Models
        1.2.4 Syngeneic Tumor Mouse Models
        1.2.5 Immunodeficient Mouse Models
        1.2.6 NOG Mouse Models
        1.2.7 Spontaneous Tumor Mouse Models
        1.2.8 Others
    1.3 Global Cancer Mouse Models Market by Application
        1.3.1 Overview: Global Cancer Mouse Models Market Size by Application: 2017 Versus 2021 Versus 2028
        1.3.2 Contract Research Organizations
        1.3.3 Pharma and Biopharma Companies
        1.3.4 Academic and Research Institutes
    1.4 Global Cancer Mouse Models Market Size & Forecast
    1.5 Global Cancer Mouse Models Market Size and Forecast by Region
        1.5.1 Global Cancer Mouse Models Market Size by Region: 2017 VS 2021 VS 2028
        1.5.2 Global Cancer Mouse Models Market Size by Region, (2017-2022)
        1.5.3 North America Cancer Mouse Models Market Size and Prospect (2017-2028)
        1.5.4 Europe Cancer Mouse Models Market Size and Prospect (2017-2028)
        1.5.5 Asia-Pacific Cancer Mouse Models Market Size and Prospect (2017-2028)
        1.5.6 South America Cancer Mouse Models Market Size and Prospect (2017-2028)
        1.5.7 Middle East and Africa Cancer Mouse Models Market Size and Prospect (2017-2028)
    1.6 Market Drivers, Restraints and Trends
        1.6.1 Cancer Mouse Models Market Drivers
        1.6.2 Cancer Mouse Models Market Restraints
        1.6.3 Cancer Mouse Models Trends Analysis

2 Company Profiles
    2.1 The Jackson Laboratory
        2.1.1 The Jackson Laboratory Details
        2.1.2 The Jackson Laboratory Major Business
        2.1.3 The Jackson Laboratory Cancer Mouse Models Product and Solutions
        2.1.4 The Jackson Laboratory Cancer Mouse Models Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
        2.1.5 The Jackson Laboratory Recent Developments and Future Plans
    2.2 Taconic Biosciences
        2.2.1 Taconic Biosciences Details
        2.2.2 Taconic Biosciences Major Business
        2.2.3 Taconic Biosciences Cancer Mouse Models Product and Solutions
        2.2.4 Taconic Biosciences Cancer Mouse Models Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
        2.2.5 Taconic Biosciences Recent Developments and Future Plans
    2.3 Charles River Laboratories
        2.3.1 Charles River Laboratories Details
        2.3.2 Charles River Laboratories Major Business
        2.3.3 Charles River Laboratories Cancer Mouse Models Product and Solutions
        2.3.4 Charles River Laboratories Cancer Mouse Models Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
        2.3.5 Charles River Laboratories Recent Developments and Future Plans
    2.4 Shanghai Model Organisms Center Inc.
        2.4.1 Shanghai Model Organisms Center Inc. Details
        2.4.2 Shanghai Model Organisms Center Inc. Major Business
        2.4.3 Shanghai Model Organisms Center Inc. Cancer Mouse Models Product and Solutions
        2.4.4 Shanghai Model Organisms Center Inc. Cancer Mouse Models Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
        2.4.5 Shanghai Model Organisms Center Inc. Recent Developments and Future Plans
    2.5 Envigo
        2.5.1 Envigo Details
        2.5.2 Envigo Major Business
        2.5.3 Envigo Cancer Mouse Models Product and Solutions
        2.5.4 Envigo Cancer Mouse Models Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
        2.5.5 Envigo Recent Developments and Future Plans
    2.6 Biocytogen
        2.6.1 Biocytogen Details
        2.6.2 Biocytogen Major Business
        2.6.3 Biocytogen Cancer Mouse Models Product and Solutions
        2.6.4 Biocytogen Cancer Mouse Models Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
        2.6.5 Biocytogen Recent Developments and Future Plans
    2.7 Genoway
        2.7.1 Genoway Details
        2.7.2 Genoway Major Business
        2.7.3 Genoway Cancer Mouse Models Product and Solutions
        2.7.4 Genoway Cancer Mouse Models Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
        2.7.5 Genoway Recent Developments and Future Plans
    2.8 Crown Bioscience Inc. (JSR Corporation).
        2.8.1 Crown Bioscience Inc. (JSR Corporation). Details
        2.8.2 Crown Bioscience Inc. (JSR Corporation). Major Business
        2.8.3 Crown Bioscience Inc. (JSR Corporation). Cancer Mouse Models Product and Solutions
        2.8.4 Crown Bioscience Inc. (JSR Corporation). Cancer Mouse Models Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
        2.8.5 Crown Bioscience Inc. (JSR Corporation). Recent Developments and Future Plans
    2.9 Cyagen
        2.9.1 Cyagen Details
        2.9.2 Cyagen Major Business
        2.9.3 Cyagen Cancer Mouse Models Product and Solutions
        2.9.4 Cyagen Cancer Mouse Models Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
        2.9.5 Cyagen Recent Developments and Future Plans
    2.10 Applied stem cells
        2.10.1 Applied stem cells Details
        2.10.2 Applied stem cells Major Business
        2.10.3 Applied stem cells Cancer Mouse Models Product and Solutions
        2.10.4 Applied stem cells Cancer Mouse Models Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
        2.10.5 Applied stem cells Recent Developments and Future Plans
    2.11 Ingenious Targeting Laboratory
        2.11.1 Ingenious Targeting Laboratory Details
        2.11.2 Ingenious Targeting Laboratory Major Business
        2.11.3 Ingenious Targeting Laboratory Cancer Mouse Models Product and Solutions
        2.11.4 Ingenious Targeting Laboratory Cancer Mouse Models Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
        2.11.5 Ingenious Targeting Laboratory Recent Developments and Future Plans
    2.12 PolyGene - Transgenic mice model company
        2.12.1 PolyGene - Transgenic mice model company Details
        2.12.2 PolyGene - Transgenic mice model company Major Business
        2.12.3 PolyGene - Transgenic mice model company Cancer Mouse Models Product and Solutions
        2.12.4 PolyGene - Transgenic mice model company Cancer Mouse Models Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
        2.12.5 PolyGene - Transgenic mice model company Recent Developments and Future Plans
    2.13 Creative Biolabs
        2.13.1 Creative Biolabs Details
        2.13.2 Creative Biolabs Major Business
        2.13.3 Creative Biolabs Cancer Mouse Models Product and Solutions
        2.13.4 Creative Biolabs Cancer Mouse Models Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
        2.13.5 Creative Biolabs Recent Developments and Future Plans
    2.14 TransCure Bioservices
        2.14.1 TransCure Bioservices Details
        2.14.2 TransCure Bioservices Major Business
        2.14.3 TransCure Bioservices Cancer Mouse Models Product and Solutions
        2.14.4 TransCure Bioservices Cancer Mouse Models Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
        2.14.5 TransCure Bioservices Recent Developments and Future Plans
    2.15 Champions Oncology Inc
        2.15.1 Champions Oncology Inc Details
        2.15.2 Champions Oncology Inc Major Business
        2.15.3 Champions Oncology Inc Cancer Mouse Models Product and Solutions
        2.15.4 Champions Oncology Inc Cancer Mouse Models Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
        2.15.5 Champions Oncology Inc Recent Developments and Future Plans
    2.16 Certis Oncology
        2.16.1 Certis Oncology Details
        2.16.2 Certis Oncology Major Business
        2.16.3 Certis Oncology Cancer Mouse Models Product and Solutions
        2.16.4 Certis Oncology Cancer Mouse Models Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
        2.16.5 Certis Oncology Recent Developments and Future Plans
    2.17 Signature
        2.17.1 Signature Details
        2.17.2 Signature Major Business
        2.17.3 Signature Cancer Mouse Models Product and Solutions
        2.17.4 Signature Cancer Mouse Models Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
        2.17.5 Signature Recent Developments and Future Plans
    2.18 Pharmaron
        2.18.1 Pharmaron Details
        2.18.2 Pharmaron Major Business
        2.18.3 Pharmaron Cancer Mouse Models Product and Solutions
        2.18.4 Pharmaron Cancer Mouse Models Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
        2.18.5 Pharmaron Recent Developments and Future Plans
    2.19 Laboratory Corporation of America Holdings
        2.19.1 Laboratory Corporation of America Holdings Details
        2.19.2 Laboratory Corporation of America Holdings Major Business
        2.19.3 Laboratory Corporation of America Holdings Cancer Mouse Models Product and Solutions
        2.19.4 Laboratory Corporation of America Holdings Cancer Mouse Models Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
        2.19.5 Laboratory Corporation of America Holdings Recent Developments and Future Plans
    2.20 Gempharmatech
        2.20.1 Gempharmatech Details
        2.20.2 Gempharmatech Major Business
        2.20.3 Gempharmatech Cancer Mouse Models Product and Solutions
        2.20.4 Gempharmatech Cancer Mouse Models Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
        2.20.5 Gempharmatech Recent Developments and Future Plans
    2.21 Janvier Labs
        2.21.1 Janvier Labs Details
        2.21.2 Janvier Labs Major Business
        2.21.3 Janvier Labs Cancer Mouse Models Product and Solutions
        2.21.4 Janvier Labs Cancer Mouse Models Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
        2.21.5 Janvier Labs Recent Developments and Future Plans
    2.22 Harbour BioMed
        2.22.1 Harbour BioMed Details
        2.22.2 Harbour BioMed Major Business
        2.22.3 Harbour BioMed Cancer Mouse Models Product and Solutions
        2.22.4 Harbour BioMed Cancer Mouse Models Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
        2.22.5 Harbour BioMed Recent Developments and Future Plans

3 Market Competition, by Players
    3.1 Global Cancer Mouse Models Revenue and Share by Players (2019, 2020, 2021, and 2022)
    3.2 Market Concentration Rate
        3.2.1 Top 3 Cancer Mouse Models Players Market Share in 2021
        3.2.2 Top 10 Cancer Mouse Models Players Market Share in 2021
        3.2.3 Market Competition Trend
    3.3 Cancer Mouse Models Players Head Office, Products and Services Provided
    3.4 Cancer Mouse Models Mergers & Acquisitions
    3.5 Cancer Mouse Models New Entrants and Expansion Plans

4 Market Size Segment by Type
    4.1 Global Cancer Mouse Models Revenue and Market Share by Type (2017-2022)
    4.2 Global Cancer Mouse Models Market Forecast by Type (2023-2028)

5 Market Size Segment by Application
    5.1 Global Cancer Mouse Models Revenue Market Share by Application (2017-2022)
    5.2 Global Cancer Mouse Models Market Forecast by Application (2023-2028)

6 North America by Country, by Type, and by Application
    6.1 North America Cancer Mouse Models Revenue by Type (2017-2028)
    6.2 North America Cancer Mouse Models Revenue by Application (2017-2028)
    6.3 North America Cancer Mouse Models Market Size by Country
        6.3.1 North America Cancer Mouse Models Revenue by Country (2017-2028)
        6.3.2 United States Cancer Mouse Models Market Size and Forecast (2017-2028)
        6.3.3 Canada Cancer Mouse Models Market Size and Forecast (2017-2028)
        6.3.4 Mexico Cancer Mouse Models Market Size and Forecast (2017-2028)

7 Europe by Country, by Type, and by Application
    7.1 Europe Cancer Mouse Models Revenue by Type (2017-2028)
    7.2 Europe Cancer Mouse Models Revenue by Application (2017-2028)
    7.3 Europe Cancer Mouse Models Market Size by Country
        7.3.1 Europe Cancer Mouse Models Revenue by Country (2017-2028)
        7.3.2 Germany Cancer Mouse Models Market Size and Forecast (2017-2028)
        7.3.3 France Cancer Mouse Models Market Size and Forecast (2017-2028)
        7.3.4 United Kingdom Cancer Mouse Models Market Size and Forecast (2017-2028)
        7.3.5 Russia Cancer Mouse Models Market Size and Forecast (2017-2028)
        7.3.6 Italy Cancer Mouse Models Market Size and Forecast (2017-2028)

8 Asia-Pacific by Region, by Type, and by Application
    8.1 Asia-Pacific Cancer Mouse Models Revenue by Type (2017-2028)
    8.2 Asia-Pacific Cancer Mouse Models Revenue by Application (2017-2028)
    8.3 Asia-Pacific Cancer Mouse Models Market Size by Region
        8.3.1 Asia-Pacific Cancer Mouse Models Revenue by Region (2017-2028)
        8.3.2 China Cancer Mouse Models Market Size and Forecast (2017-2028)
        8.3.3 Japan Cancer Mouse Models Market Size and Forecast (2017-2028)
        8.3.4 South Korea Cancer Mouse Models Market Size and Forecast (2017-2028)
        8.3.5 India Cancer Mouse Models Market Size and Forecast (2017-2028)
        8.3.6 Southeast Asia Cancer Mouse Models Market Size and Forecast (2017-2028)
        8.3.7 Australia Cancer Mouse Models Market Size and Forecast (2017-2028)

9 South America by Country, by Type, and by Application
    9.1 South America Cancer Mouse Models Revenue by Type (2017-2028)
    9.2 South America Cancer Mouse Models Revenue by Application (2017-2028)
    9.3 South America Cancer Mouse Models Market Size by Country
        9.3.1 South America Cancer Mouse Models Revenue by Country (2017-2028)
        9.3.2 Brazil Cancer Mouse Models Market Size and Forecast (2017-2028)
        9.3.3 Argentina Cancer Mouse Models Market Size and Forecast (2017-2028)

10 Middle East & Africa by Country, by Type, and by Application
    10.1 Middle East & Africa Cancer Mouse Models Revenue by Type (2017-2028)
    10.2 Middle East & Africa Cancer Mouse Models Revenue by Application (2017-2028)
    10.3 Middle East & Africa Cancer Mouse Models Market Size by Country
        10.3.1 Middle East & Africa Cancer Mouse Models Revenue by Country (2017-2028)
        10.3.2 Turkey Cancer Mouse Models Market Size and Forecast (2017-2028)
        10.3.3 Saudi Arabia Cancer Mouse Models Market Size and Forecast (2017-2028)
        10.3.4 UAE Cancer Mouse Models Market Size and Forecast (2017-2028)

11 Research Findings and Conclusion

12 Appendix
    12.1 Methodology
    12.2 Research Process and Data Source
    12.3 Disclaimer

Table of Figures

List of Tables
    Table 1. Global Cancer Mouse Models Revenue by Type, (USD Million), 2017 VS 2021 VS 2028
    Table 2. Global Cancer Mouse Models Revenue by Application, (USD Million), 2017 VS 2021 VS 2028
    Table 3. Global Market Cancer Mouse Models Revenue (Million USD) Comparison by Region (2017 VS 2021 VS 2028)
    Table 4. Global Cancer Mouse Models Revenue (USD Million) by Region (2017-2022)
    Table 5. Global Cancer Mouse Models Revenue Market Share by Region (2023-2028)
    Table 6. The Jackson Laboratory Corporate Information, Head Office, and Major Competitors
    Table 7. The Jackson Laboratory Major Business
    Table 8. The Jackson Laboratory Cancer Mouse Models Product and Solutions
    Table 9. The Jackson Laboratory Cancer Mouse Models Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    Table 10. Taconic Biosciences Corporate Information, Head Office, and Major Competitors
    Table 11. Taconic Biosciences Major Business
    Table 12. Taconic Biosciences Cancer Mouse Models Product and Solutions
    Table 13. Taconic Biosciences Cancer Mouse Models Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    Table 14. Charles River Laboratories Corporate Information, Head Office, and Major Competitors
    Table 15. Charles River Laboratories Major Business
    Table 16. Charles River Laboratories Cancer Mouse Models Product and Solutions
    Table 17. Charles River Laboratories Cancer Mouse Models Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    Table 18. Shanghai Model Organisms Center Inc. Corporate Information, Head Office, and Major Competitors
    Table 19. Shanghai Model Organisms Center Inc. Major Business
    Table 20. Shanghai Model Organisms Center Inc. Cancer Mouse Models Product and Solutions
    Table 21. Shanghai Model Organisms Center Inc. Cancer Mouse Models Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    Table 22. Envigo Corporate Information, Head Office, and Major Competitors
    Table 23. Envigo Major Business
    Table 24. Envigo Cancer Mouse Models Product and Solutions
    Table 25. Envigo Cancer Mouse Models Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    Table 26. Biocytogen Corporate Information, Head Office, and Major Competitors
    Table 27. Biocytogen Major Business
    Table 28. Biocytogen Cancer Mouse Models Product and Solutions
    Table 29. Biocytogen Cancer Mouse Models Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    Table 30. Genoway Corporate Information, Head Office, and Major Competitors
    Table 31. Genoway Major Business
    Table 32. Genoway Cancer Mouse Models Product and Solutions
    Table 33. Genoway Cancer Mouse Models Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    Table 34. Crown Bioscience Inc. (JSR Corporation). Corporate Information, Head Office, and Major Competitors
    Table 35. Crown Bioscience Inc. (JSR Corporation). Major Business
    Table 36. Crown Bioscience Inc. (JSR Corporation). Cancer Mouse Models Product and Solutions
    Table 37. Crown Bioscience Inc. (JSR Corporation). Cancer Mouse Models Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    Table 38. Cyagen Corporate Information, Head Office, and Major Competitors
    Table 39. Cyagen Major Business
    Table 40. Cyagen Cancer Mouse Models Product and Solutions
    Table 41. Cyagen Cancer Mouse Models Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    Table 42. Applied stem cells Corporate Information, Head Office, and Major Competitors
    Table 43. Applied stem cells Major Business
    Table 44. Applied stem cells Cancer Mouse Models Product and Solutions
    Table 45. Applied stem cells Cancer Mouse Models Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    Table 46. Ingenious Targeting Laboratory Corporate Information, Head Office, and Major Competitors
    Table 47. Ingenious Targeting Laboratory Major Business
    Table 48. Ingenious Targeting Laboratory Cancer Mouse Models Product and Solutions
    Table 49. Ingenious Targeting Laboratory Cancer Mouse Models Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    Table 50. PolyGene - Transgenic mice model company Corporate Information, Head Office, and Major Competitors
    Table 51. PolyGene - Transgenic mice model company Major Business
    Table 52. PolyGene - Transgenic mice model company Cancer Mouse Models Product and Solutions
    Table 53. PolyGene - Transgenic mice model company Cancer Mouse Models Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    Table 54. Creative Biolabs Corporate Information, Head Office, and Major Competitors
    Table 55. Creative Biolabs Major Business
    Table 56. Creative Biolabs Cancer Mouse Models Product and Solutions
    Table 57. Creative Biolabs Cancer Mouse Models Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    Table 58. TransCure Bioservices Corporate Information, Head Office, and Major Competitors
    Table 59. TransCure Bioservices Major Business
    Table 60. TransCure Bioservices Cancer Mouse Models Product and Solutions
    Table 61. TransCure Bioservices Cancer Mouse Models Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    Table 62. Champions Oncology Inc Corporate Information, Head Office, and Major Competitors
    Table 63. Champions Oncology Inc Major Business
    Table 64. Champions Oncology Inc Cancer Mouse Models Product and Solutions
    Table 65. Champions Oncology Inc Cancer Mouse Models Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    Table 66. Certis Oncology Corporate Information, Head Office, and Major Competitors
    Table 67. Certis Oncology Major Business
    Table 68. Certis Oncology Cancer Mouse Models Product and Solutions
    Table 69. Certis Oncology Cancer Mouse Models Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    Table 70. Signature Corporate Information, Head Office, and Major Competitors
    Table 71. Signature Major Business
    Table 72. Signature Cancer Mouse Models Product and Solutions
    Table 73. Signature Cancer Mouse Models Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    Table 74. Pharmaron Corporate Information, Head Office, and Major Competitors
    Table 75. Pharmaron Major Business
    Table 76. Pharmaron Cancer Mouse Models Product and Solutions
    Table 77. Pharmaron Cancer Mouse Models Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    Table 78. Laboratory Corporation of America Holdings Corporate Information, Head Office, and Major Competitors
    Table 79. Laboratory Corporation of America Holdings Major Business
    Table 80. Laboratory Corporation of America Holdings Cancer Mouse Models Product and Solutions
    Table 81. Laboratory Corporation of America Holdings Cancer Mouse Models Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    Table 82. Gempharmatech Corporate Information, Head Office, and Major Competitors
    Table 83. Gempharmatech Major Business
    Table 84. Gempharmatech Cancer Mouse Models Product and Solutions
    Table 85. Gempharmatech Cancer Mouse Models Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    Table 86. Janvier Labs Corporate Information, Head Office, and Major Competitors
    Table 87. Janvier Labs Major Business
    Table 88. Janvier Labs Cancer Mouse Models Product and Solutions
    Table 89. Janvier Labs Cancer Mouse Models Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    Table 90. Harbour BioMed Corporate Information, Head Office, and Major Competitors
    Table 91. Harbour BioMed Major Business
    Table 92. Harbour BioMed Cancer Mouse Models Product and Solutions
    Table 93. Harbour BioMed Cancer Mouse Models Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    Table 94. Global Cancer Mouse Models Revenue (USD Million) by Players (2019, 2020, 2021, and 2022)
    Table 95. Global Cancer Mouse Models Revenue Share by Players (2019, 2020, 2021, and 2022)
    Table 96. Breakdown of Cancer Mouse Models by Company Type (Tier 1, Tier 2 and Tier 3)
    Table 97. Cancer Mouse Models Players Head Office, Products and Services Provided
    Table 98. Cancer Mouse Models Mergers & Acquisitions in the Past Five Years
    Table 99. Cancer Mouse Models New Entrants and Expansion Plans
    Table 100. Global Cancer Mouse Models Revenue (USD Million) by Type (2017-2022)
    Table 101. Global Cancer Mouse Models Revenue Share by Type (2017-2022)
    Table 102. Global Cancer Mouse Models Revenue Forecast by Type (2023-2028)
    Table 103. Global Cancer Mouse Models Revenue by Application (2017-2022)
    Table 104. Global Cancer Mouse Models Revenue Forecast by Application (2023-2028)
    Table 105. North America Cancer Mouse Models Revenue by Type (2017-2022) & (USD Million)
    Table 106. North America Cancer Mouse Models Revenue by Type (2023-2028) & (USD Million)
    Table 107. North America Cancer Mouse Models Revenue by Application (2017-2022) & (USD Million)
    Table 108. North America Cancer Mouse Models Revenue by Application (2023-2028) & (USD Million)
    Table 109. North America Cancer Mouse Models Revenue by Country (2017-2022) & (USD Million)
    Table 110. North America Cancer Mouse Models Revenue by Country (2023-2028) & (USD Million)
    Table 111. Europe Cancer Mouse Models Revenue by Type (2017-2022) & (USD Million)
    Table 112. Europe Cancer Mouse Models Revenue by Type (2023-2028) & (USD Million)
    Table 113. Europe Cancer Mouse Models Revenue by Application (2017-2022) & (USD Million)
    Table 114. Europe Cancer Mouse Models Revenue by Application (2023-2028) & (USD Million)
    Table 115. Europe Cancer Mouse Models Revenue by Country (2017-2022) & (USD Million)
    Table 116. Europe Cancer Mouse Models Revenue by Country (2023-2028) & (USD Million)
    Table 117. Asia-Pacific Cancer Mouse Models Revenue by Type (2017-2022) & (USD Million)
    Table 118. Asia-Pacific Cancer Mouse Models Revenue by Type (2023-2028) & (USD Million)
    Table 119. Asia-Pacific Cancer Mouse Models Revenue by Application (2017-2022) & (USD Million)
    Table 120. Asia-Pacific Cancer Mouse Models Revenue by Application (2023-2028) & (USD Million)
    Table 121. Asia-Pacific Cancer Mouse Models Revenue by Region (2017-2022) & (USD Million)
    Table 122. Asia-Pacific Cancer Mouse Models Revenue by Region (2023-2028) & (USD Million)
    Table 123. South America Cancer Mouse Models Revenue by Type (2017-2022) & (USD Million)
    Table 124. South America Cancer Mouse Models Revenue by Type (2023-2028) & (USD Million)
    Table 125. South America Cancer Mouse Models Revenue by Application (2017-2022) & (USD Million)
    Table 126. South America Cancer Mouse Models Revenue by Application (2023-2028) & (USD Million)
    Table 127. South America Cancer Mouse Models Revenue by Country (2017-2022) & (USD Million)
    Table 128. South America Cancer Mouse Models Revenue by Country (2023-2028) & (USD Million)
    Table 129. Middle East & Africa Cancer Mouse Models Revenue by Type (2017-2022) & (USD Million)
    Table 130. Middle East & Africa Cancer Mouse Models Revenue by Type (2023-2028) & (USD Million)
    Table 131. Middle East & Africa Cancer Mouse Models Revenue by Application (2017-2022) & (USD Million)
    Table 132. Middle East & Africa Cancer Mouse Models Revenue by Application (2023-2028) & (USD Million)
    Table 133. Middle East & Africa Cancer Mouse Models Revenue by Country (2017-2022) & (USD Million)
    Table 134. Middle East & Africa Cancer Mouse Models Revenue by Country (2023-2028) & (USD Million)
List of Figures
    Figure 1. Cancer Mouse Models Picture
    Figure 2. Global Cancer Mouse Models Revenue Market Share by Type in 2021
    Figure 3. Humanized Immune System Mouse Models
    Figure 4. Syngeneic Tumor Mouse Models
    Figure 5. Immunodeficient Mouse Models
    Figure 6. NOG Mouse Models
    Figure 7. Spontaneous Tumor Mouse Models
    Figure 8. Others
    Figure 9. Cancer Mouse Models Revenue Market Share by Application in 2021
    Figure 10. Contract Research Organizations Picture
    Figure 11. Pharma and Biopharma Companies Picture
    Figure 12. Academic and Research Institutes Picture
    Figure 13. Global Cancer Mouse Models Market Size, (USD Million): 2017 VS 2021 VS 2028
    Figure 14. Global Cancer Mouse Models Revenue and Forecast (2017-2028) & (USD Million)
    Figure 15. Global Cancer Mouse Models Revenue Market Share by Region (2017-2028)
    Figure 16. Global Cancer Mouse Models Revenue Market Share by Region in 2021
    Figure 17. North America Cancer Mouse Models Revenue (USD Million) and Growth Rate (2017-2028)
    Figure 18. Europe Cancer Mouse Models Revenue (USD Million) and Growth Rate (2017-2028)
    Figure 19. Asia-Pacific Cancer Mouse Models Revenue (USD Million) and Growth Rate (2017-2028)
    Figure 20. South America Cancer Mouse Models Revenue (USD Million) and Growth Rate (2017-2028)
    Figure 21. Middle East and Africa Cancer Mouse Models Revenue (USD Million) and Growth Rate (2017-2028)
    Figure 22. Cancer Mouse Models Market Drivers
    Figure 23. Cancer Mouse Models Market Restraints
    Figure 24. Cancer Mouse Models Market Trends
    Figure 25. The Jackson Laboratory Recent Developments and Future Plans
    Figure 26. Taconic Biosciences Recent Developments and Future Plans
    Figure 27. Charles River Laboratories Recent Developments and Future Plans
    Figure 28. Shanghai Model Organisms Center Inc. Recent Developments and Future Plans
    Figure 29. Envigo Recent Developments and Future Plans
    Figure 30. Biocytogen Recent Developments and Future Plans
    Figure 31. Genoway Recent Developments and Future Plans
    Figure 32. Crown Bioscience Inc. (JSR Corporation). Recent Developments and Future Plans
    Figure 33. Cyagen Recent Developments and Future Plans
    Figure 34. Applied stem cells Recent Developments and Future Plans
    Figure 35. Ingenious Targeting Laboratory Recent Developments and Future Plans
    Figure 36. PolyGene - Transgenic mice model company Recent Developments and Future Plans
    Figure 37. Creative Biolabs Recent Developments and Future Plans
    Figure 38. TransCure Bioservices Recent Developments and Future Plans
    Figure 39. Champions Oncology Inc Recent Developments and Future Plans
    Figure 40. Certis Oncology Recent Developments and Future Plans
    Figure 41. Signature Recent Developments and Future Plans
    Figure 42. Pharmaron Recent Developments and Future Plans
    Figure 43. Laboratory Corporation of America Holdings Recent Developments and Future Plans
    Figure 44. Gempharmatech Recent Developments and Future Plans
    Figure 45. Janvier Labs Recent Developments and Future Plans
    Figure 46. Harbour BioMed Recent Developments and Future Plans
    Figure 47. Global Cancer Mouse Models Revenue Share by Players in 2021
    Figure 48. Cancer Mouse Models Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2021
    Figure 49. Global Top 3 Players Cancer Mouse Models Revenue Market Share in 2021
    Figure 50. Global Top 10 Players Cancer Mouse Models Revenue Market Share in 2021
    Figure 51. Key Players Market Share Trend (Top 3 Market Share: 2020 VS 2021 VS 2022)
    Figure 52. Global Cancer Mouse Models Revenue Share by Type in 2021
    Figure 53. Global Cancer Mouse Models Market Share Forecast by Type (2023-2028)
    Figure 54. Global Cancer Mouse Models Revenue Share by Application in 2021
    Figure 55. Global Cancer Mouse Models Market Share Forecast by Application (2023-2028)
    Figure 56. North America Cancer Mouse Models Sales Market Share by Type (2017-2028)
    Figure 57. North America Cancer Mouse Models Sales Market Share by Application (2017-2028)
    Figure 58. North America Cancer Mouse Models Revenue Market Share by Country (2017-2028)
    Figure 59. United States Cancer Mouse Models Revenue and Growth Rate (2017-2028) & (USD Million)
    Figure 60. Canada Cancer Mouse Models Revenue and Growth Rate (2017-2028) & (USD Million)
    Figure 61. Mexico Cancer Mouse Models Revenue and Growth Rate (2017-2028) & (USD Million)
    Figure 62. Europe Cancer Mouse Models Sales Market Share by Type (2017-2028)
    Figure 63. Europe Cancer Mouse Models Sales Market Share by Application (2017-2028)
    Figure 64. Europe Cancer Mouse Models Revenue Market Share by Country (2017-2028)
    Figure 65. Germany Cancer Mouse Models Revenue and Growth Rate (2017-2028) & (USD Million)
    Figure 66. France Cancer Mouse Models Revenue and Growth Rate (2017-2028) & (USD Million)
    Figure 67. United Kingdom Cancer Mouse Models Revenue and Growth Rate (2017-2028) & (USD Million)
    Figure 68. Russia Cancer Mouse Models Revenue and Growth Rate (2017-2028) & (USD Million)
    Figure 69. Italy Cancer Mouse Models Revenue and Growth Rate (2017-2028) & (USD Million)
    Figure 70. Asia-Pacific Cancer Mouse Models Sales Market Share by Type (2017-2028)
    Figure 71. Asia-Pacific Cancer Mouse Models Sales Market Share by Application (2017-2028)
    Figure 72. Asia-Pacific Cancer Mouse Models Revenue Market Share by Region (2017-2028)
    Figure 73. China Cancer Mouse Models Revenue and Growth Rate (2017-2028) & (USD Million)
    Figure 74. Japan Cancer Mouse Models Revenue and Growth Rate (2017-2028) & (USD Million)
    Figure 75. South Korea Cancer Mouse Models Revenue and Growth Rate (2017-2028) & (USD Million)
    Figure 76. India Cancer Mouse Models Revenue and Growth Rate (2017-2028) & (USD Million)
    Figure 77. Southeast Asia Cancer Mouse Models Revenue and Growth Rate (2017-2028) & (USD Million)
    Figure 78. Australia Cancer Mouse Models Revenue and Growth Rate (2017-2028) & (USD Million)
    Figure 79. South America Cancer Mouse Models Sales Market Share by Type (2017-2028)
    Figure 80. South America Cancer Mouse Models Sales Market Share by Application (2017-2028)
    Figure 81. South America Cancer Mouse Models Revenue Market Share by Country (2017-2028)
    Figure 82. Brazil Cancer Mouse Models Revenue and Growth Rate (2017-2028) & (USD Million)
    Figure 83. Argentina Cancer Mouse Models Revenue and Growth Rate (2017-2028) & (USD Million)
    Figure 84. Middle East and Africa Cancer Mouse Models Sales Market Share by Type (2017-2028)
    Figure 85. Middle East and Africa Cancer Mouse Models Sales Market Share by Application (2017-2028)
    Figure 86. Middle East and Africa Cancer Mouse Models Revenue Market Share by Country (2017-2028)
    Figure 87. Turkey Cancer Mouse Models Revenue and Growth Rate (2017-2028) & (USD Million)
    Figure 88. Saudi Arabia Cancer Mouse Models Revenue and Growth Rate (2017-2028) & (USD Million)
    Figure 89. UAE Cancer Mouse Models Revenue and Growth Rate (2017-2028) & (USD Million)
    Figure 90. Methodology
    Figure 91. Research Process and Data Source

Research Methodology

Client Requirements

Review and analyze client requirements

Discussion of all the project requirements and queries

Flexibility Check

Project Feasibility Analysis

Finalizing tentative research programme

Structuring project proposal with scope, timeline, and costs

Analyzing Market Dynamics

Determination of key drivers, restraints, challenge, and opportunity

Identifies market needs and trends

Market Size Estimation & Forecast

Estimation of historical data based on secondary and primary data

Anticipating market recast by assigning weightage to market forces (drivers, restraints, opportunities)

Freezing historical and forecast market size estimations based on evolution, trends, outlook, and strategies

Consideration of geography, region-specific product/service demand for region segments

Consideration of product utilization rates, product demand outlook for segments by application or end-user.

Data Source

Secondary Source
Data collections from annual reports, presentations,associations, journals, analyst reports, paid database, press releases, blogs, newsletters,and GIR repositories.

Primary Source
Research discussion with manufacturers, distributors, suppliers, end user, industry experts to verify insights.

Validation and
triangulation of
secondary and primary source.

Collection of data

Cumulating and collating the essential qualitative and quantitative data

Generation of report in client requested format by research analysts

Reviews by expert analysts

Final quality check

Clarifying queries

Receiving feedback

Ensuring satisfaction

01 Identification of data

This step involves identification of several primary and secondary data research sources, including Global Info Research's internal data sources. The primary sources consist of in-depth discussions and interviews with policy makers, industry experts, and data evaluators, whereas secondary sources include a thorough study of market journals, press releases, annual reports, and government and non-government agencies websites.
02 Evaluation of Market Dynamic

This phase includes a detailed evaluation of several factors that are likely to affect the market dynamics. It involves a comprehensive assessment of major market pain points, drivers, and trends. It also comprises a detailed study of research plans and methodology.
03 Collection of Data

This process consists of gathering data, accessing proprietary databases, and reaching out to key industry participants that operate in the market across the value chain. It also involves studying several patterns in the historical data and comparing it with the current scenario.
04 Collaboration of Data

This stage involves the validation of data and arrival at actual statistics, and evolution of the market over the years. It entails the study and analyzes various segments and verticals of the market. An impact analysis is also performed to observe which factors will affect the market in the next few years.
05 Verification and Analysis

This is the final stage, which involves both quantity and quality checks. Although the process of data verification is an integral part of the research process, all data points and statistics and figures are re-checked to uphold their authenticity and validity.

Companies Mentioned

The Jackson Laboratory
Taconic Biosciences
Charles River Laboratories
Shanghai Model Organisms Center Inc.
Envigo
Biocytogen
Genoway
Crown Bioscience Inc. (JSR Corporation).
Cyagen
Applied stem cells
Ingenious Targeting Laboratory
PolyGene - Transgenic mice model company
Creative Biolabs
TransCure Bioservices
Champions Oncology Inc
Certis Oncology
Signature
Pharmaron
Laboratory Corporation of America Holdings
Gempharmatech
Janvier Labs
Harbour BioMed

Related Reports

Global Cancer Mouse Models Supply, Demand and Key Producers, 2023-2029

Global Cancer Mouse Models Supply, Demand and Key Producers, 2023-2029

date 23 Feb 2023

date Service & Software

The global Cancer Mouse Models market size is expected to reach $ million by 2029, rising at a market growth of % CAGR during the forecast period (2023-2029).

Global Cancer Mouse Models Market 2024 by Company, Regions, Type and Application, Forecast to 2030

Global Cancer Mouse Models Market 2024 by Company, Regions, Type and Application, Forecast to 2030

date 02 Jan 2024

date Service & Software

According to our (Global Info Research) latest study, the global Cancer Mouse Models market size was valued at USD million in 2023 and is forecast to a readjusted size of USD million by 2030 with a CAGR of % during review period.

Product Tags

cancer mouse models

soil fertility

Image High Dynamic

Building Energy Modeling

Purchase Options

Single User License

USD3480.00

Multi User License

USD5220.00

Corporate Users License

USD6960.00

Add To Cart

Buy Now

Popular Product Keywords

AI
semiconductor
electron
5G
artificial intelligence
Battery
new energy
We Provide Professional, Accurate Market Analysis to Help You Stay Ahead of Your Competition.

Speak to our analyst >>
Our Clients
What We Can Provide?

With better results and higher quality products,Our professional reports can achieve four things:
- Insight into the industry market information
- Analyze market development needs
- Prospects for future development
- Develop industry investment strategy
Digging deeper into global industry information and providing market strategies.

Contact Us >>